Phase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Malignancies or Untreated Acute Myeloid Leukemia

Clinical trial NCT02381548 · TERMINATED

Trial details

NCT number: NCT02381548
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Acute Myeloid Leukemia Post Cytotoxic Therapy Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive Myelodysplastic Syndrome Recurrent Adult Acute Myeloid Leukemia Recurrent Chronic Myeloid Leukemia, BCR-ABL1 Positive Refractory Acute Myeloid Leukemia Refractory Chronic Myeloid Leukemia, BCR-ABL1 Positive Secondary Acute Myeloid Leukemia

Start date: 2015-08-18
Primary completion: 2018-05-23
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.